Fast-Track FDA Reviews: Legal Concerns Loom for Drugmakers
Published on: Jan. 16, 2026, 7:18 p.m. | Source: Devdiscourse
Major drugmakers are participating in a new FDA fast-track review program despite concerns about potential legal risks. The program aims to expedite drug approvals deemed critical to public health or national security, but worries persist over its impact on safety, efficacy, and FDA's regulatory role.
